Skip to main content
Top
Published in: Diabetologia 7/2020

Open Access 01-07-2020 | Mood Disorders | Article

Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study

Authors: Bowen Tang, Shuai Yuan, Ying Xiong, Qiqiang He, Susanna C. Larsson

Published in: Diabetologia | Issue 7/2020

Login to get access

Abstract

Aims/hypothesis

Observational studies have shown a bidirectional association between major depressive disorder (MDD) and cardiometabolic diseases. We conducted a two-sample bidirectional Mendelian randomisation (MR) study to assess the causal associations of MDD with type 2 diabetes, coronary artery disease (CAD) and heart failure and vice versa.

Methods

We extracted summary-level data for MDD, type 2 diabetes, CAD and heart failure from corresponding published large genome-wide association studies of individuals mainly of European-descent. In total, 96 SNPs for MDD, 202 SNPs for type 2 diabetes, 44 SNPs for CAD and 12 SNPs for heart failure were proposed as instrumental variables at the genome-wide significance level (p < 5 × 10−8). The random-effects inverse-variance weighted method was used for the main analyses.

Results

Genetic liability to MDD was significantly associated with type 2 diabetes and CAD at the Bonferroni-corrected significance level. The ORs of type 2 diabetes and CAD were respectively 1.26 (95% CI 1.10, 1.43; p = 6 × 10−4) and 1.16 (95% CI 1.05, 1.29; p = 0.0047) per one-unit increase in loge odds of MDD. There was a suggestive association between MDD and heart failure (OR 1.11 [95% CI 1.01, 1.21]; p = 0.033). We found limited evidence supporting causal effects of cardiometabolic diseases on MDD risk in the reverse MR analyses.

Conclusions/interpretation

The present study strengthened the evidence that MDD is a potential risk factor for type 2 diabetes and CAD. Whether MDD is causally related to heart failure needs further study.

Data availability

All data included in this study were uploaded as supplements and are also publicly available through published GWASs and open GWAS datasets (UK Biobank, 23andMe and Psychiatric Genomics: https://​datashare.​is.​ed.​ac.​uk/​handle/​10283/​3203; DIAGRAM: http://​diagram-consortium.​org/​downloads.​html; CARDIoGRAMplusCD4: www.​cardiogramplusc4​d.​org/​; HERMES: http://​www.​kp4cd.​org/​datasets/​mi).
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (2017) Depression and other common mental disorders: global health estimates. World Health Organization, Geneva World Health Organization (2017) Depression and other common mental disorders: global health estimates. World Health Organization, Geneva
2.
go back to reference Ogurtsova K, da Rocha Fernandes JD, Huang Y et al (2017) IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 28:40–50CrossRef Ogurtsova K, da Rocha Fernandes JD, Huang Y et al (2017) IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 28:40–50CrossRef
4.
9.
go back to reference Abramson J, Berger A, Krumholz HM, Vaccarino V (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. JAMA Intern Med 161(14):1725–1730CrossRef Abramson J, Berger A, Krumholz HM, Vaccarino V (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. JAMA Intern Med 161(14):1725–1730CrossRef
19.
go back to reference Brion M-JA, Shakhbazov K, Visscher PM (2012) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42(5):1497–1501CrossRef Brion M-JA, Shakhbazov K, Visscher PM (2012) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42(5):1497–1501CrossRef
21.
go back to reference Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan. A meta-analysis. 31(12):2383–2390 Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan. A meta-analysis. 31(12):2383–2390
22.
go back to reference Pan A, Lucas M, Sun Q et al (2010) Bidirectional association between depression and type 2 diabetes mellitus in women. JAMA Intern Med 170(21):1884–1891CrossRef Pan A, Lucas M, Sun Q et al (2010) Bidirectional association between depression and type 2 diabetes mellitus in women. JAMA Intern Med 170(21):1884–1891CrossRef
27.
go back to reference Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry 6(1):38–51PubMed Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry 6(1):38–51PubMed
28.
go back to reference He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I Epidemiologic Follow-up Study. JAMA Intern Med 161(7):996–1002CrossRef He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I Epidemiologic Follow-up Study. JAMA Intern Med 161(7):996–1002CrossRef
Metadata
Title
Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study
Authors
Bowen Tang
Shuai Yuan
Ying Xiong
Qiqiang He
Susanna C. Larsson
Publication date
01-07-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05131-6

Other articles of this Issue 7/2020

Diabetologia 7/2020 Go to the issue

UpFront

Up Front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.